EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Probiotics and nanoparticle-mediated nutrient delivery in the management of transfusion-supported diseases

Wendao Han, Nating Xiong, Lingmei Huang

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1575798 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Wendao Han und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Blood Transfusion, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, China. Hauptthemen laut MEDLINE: Probiotics, Nanoparticles, Blood Transfusion, Drug Delivery Systems. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone marrow is vital for hematopoiesis, producing blood cells essential for oxygen transport, immune defense, and clotting. However, disorders like leukemia, lymphoma, aplastic anemia, and myelodysplastic syndromes can severely disrupt its function, leading to life-threatening complications. Traditional treatments, including chemotherapy and stem cell transplants, have significantly improved patient outcomes but are often associated with severe side effects and limitations, necessitating the exploration of safer, more targeted therapeutic strategies. Nanotechnology has emerged as a promising approach for addressing these challenges, particularly in the delivery of nutraceuticals—bioactive compounds derived from food sources with potential therapeutic benefits. Despite their promise, nutraceuticals often face clinical limitations due to poor bioavailability, instability, and inefficient delivery to target sites. Nanoparticles offer a viable solution by enhancing the stability, absorption, and targeted transport of nutraceuticals to bone marrow while minimizing systemic side effects. This study explores a range of bone marrow disorders, conventional treatment modalities, and the potential of nanoparticles to enhance nutraceutical-based therapies. By improving targeted delivery and therapeutic efficacy, nanoparticles could revolutionize bone marrow disease management, providing patients with more effective and less invasive treatment options. These advancements represent a significant step toward safer and more efficient therapeutic approaches, ultimately improving patient prognosis and overall health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsNanoparticlesBlood TransfusionDrug Delivery SystemsHumansDietary SupplementsAnimalsMyelodysplastic Syndromes

Stichwörter der Autor:innen

bone marrowdisordersnanoparticlesnanotechnologynutraceuticals

Autor:innen und Institutionen

  • Department of Blood Transfusion, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, China.

Zitieren

APA

Han, W., Xiong, N., & Huang, L. (2025). Probiotics and nanoparticle-mediated nutrient delivery in the management of transfusion-supported diseases. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1575798

Vancouver

Han W, Xiong N, Huang L. Probiotics and nanoparticle-mediated nutrient delivery in the management of transfusion-supported diseases. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1575798

BibTeX
@article{Han2025,
  author = {Han, Wendao and Xiong, Nating and Huang, Lingmei},
  title = {Probiotics and nanoparticle-mediated nutrient delivery in the management of transfusion-supported diseases},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1575798}
}
Kostenlos starten →